{"ModuleTitle": "Company Description", "CompanyName": "BioCryst Pharmaceuticals, Inc.", "Symbol": "BCRX", "Address": "4505 EMPEROR BOULEVARD SUITE 200, DURHAM, North Carolina, 27703, United States of America", "Phone": "919-859-1302", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Sector": "Health Care", "Region": "North America", "CompanyDescription": "This report includes forward-looking statements within the meaning of\r\nSection 21E of the Securities Exchange Act of 1934, as amended, which are\r\nsubject to the \"safe harbor\" created in Section 21E. In particular, statements\r\nabout our expectations, beliefs, plans, objectives or assumptions of future\r\nevents or performance are contained or incorporated by reference in this report.\r\nAll statements other than statements of historical facts contained herein are\r\nforward-looking statements. We have based these forward-looking statements on\r\nour current expectations about future events. While we believe these\r\nexpectations are reasonable, forward-looking statements are inherently subject\r\nto risks and uncertainties, many of which are beyond our control. Our actual\r\nresults may differ materially from those suggested by these forward-looking\r\nstatements for various reasons, including those discussed in this report under\r\nthe heading \"Risk Factors.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2020%2f03%2f13%2f0001171843-20-001710.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "Anthony Doyle", "title": "Chief Financial Officer & Senior Vice President"}, {"name": "Jon P. Stonehouse", "title": "President, Chief Executive Officer & Director"}, {"name": "Megan Sniecinski", "title": "Chief Business Officer & Senior Vice President"}, {"name": "William P. Sheridan", "title": "Chief Medical Officer & Senior Vice President"}], "Number_of_employees": [], "Subsidiaries": ["NO INFO"]}